Performance nutrition brand Neulife has raised $1 million in its first seed funding round, co-led by Subhkam Ventures and Singularity Ventures.
Other investors in the round include Sunicon Ventures, Cosma Ventures, and several high-net-worth individuals (HNIs).
The funds will be used to develop new products, expand clinical research and trials, and grow Neulife’s protein range. The company also plans to use part of the money to expand globally and strengthen its research and development (R&D) efforts.
Samit Gupta, Founder & CEO, Neulife said, “As a carb-free ketogenic athlete myself for over a decade now, I have always struggled with my protein supplements – since they were fundamentally designed wrong, and contradict the way Protein actually occurs in nature – always with Fat source for optimal protein synthesis and energy efficiency. With Neulife, we’ve solved that problem, and are creating proteins that go beyond absorption – delivering true metabolic advantages and higher protein efficiency with our patented Ketofuel® MCT technology. In a market that has, for long, been underserved by generic, copycat supplements, we’re on a mission to plug the gap with metabolically superior Proteins that provide higher protein efficiency and absorption gram for gram against any other Protein, anywhere. The latest seed funding round serves as a key milestone in accelerating Neulife’s journey in the Premium Proteins space, validating our potential and mission, and fuelling our growth.”
Rishabh Kathotia, Partner, Subhkam Ventures commented, “We believe that Neulife is addressing critical gaps in India’s performance nutrition market with its differentiated, science-first approach. Samit and his team bring unmatched experience and R&D depth to this category, which really impressed us and prompted us to invest, helping them build a legacy in this booming industry.”
Neulife was founded in 2014 by Samit Gupta and is a performance nutrition brand focused on research and development. The company launched its direct-to-consumer (D2C) business in 2022.
It makes scientifically tested, high-performance protein products using its patented Ketofuel MCT technology.
Neulife’s main products, Pro Standard Whey (launched in 2023) and Super Isolate (launched in 2024), provide over 30% better protein absorption and efficiency compared to regular whey or plant proteins. The company’s R&D team has filed five patents, with two approved and three still pending.
Neulife plans to capture 15% of India’s premium protein market by 2028 and aims to raise another $3 million by the end of 2026 to support its expansion and new product development.
Read more- NZVC Launches $50 Million Fund II to Support 60 Founders Across Australia and New Zealand
